DOI: 10.1055/s-00000007

Aktuelle Urologie

References

Motzer RJ, Tannir NM, McDermott DF. et al.
Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma.

N Eng J Med 2018;
378: 1277-1290

Download Bibliographical Data

Access:
Access: